June 4, 2009 — The latest results from the European First Episode Schizophrenia Trial (EUFEST) show that when it comes to improving cognition in patients with schizophrenia, there is little difference ...

A new study analyzing Medicaid databases from 2017 to 2021 has uncovered significant differences in how long-acting injectable (LAI) antipsychotic medications are prescribed to older adults across ...

COLORADO SPRINGS, Colo. -- Using long-acting injectable (LAI) antipsychotic therapies rather than oral agents for schizophrenia was tied to demographic and clinical factors, a single-center ...

First-Generation Antipsychotic Drugs By Jonathan Scheff This table lists selected first-generation antipsychotic drugs. For a table of atypical agents, click here. For a table of the next generation ...

Since the first antipsychotic medication, chlorpromazine, was developed in the early 1950s, it could be argued that not all that much has changed in the pharmacological treatment of psychotic ...

Oral and parenteral antipsychotics showed similar outcomes in patients with schizophrenia experiencing agitation who presented to the emergency department (ED) with violent behavior, with no ...

While any patients taking an anti-dopaminergic agent may develop tardive dyskinesia (TD) -- a movement disorder hallmarked by abnormal and involuntary tics of the face, trunk, and limbs -- older ...